Description
Wegovy UK
Wegovy UK is a weight loss medication. If you have type 2 diabetes or prediabetes, then you might be prescribed Wegovy as an option for weight management. Wegovy, a brand name for semaglutide, belongs to a group of drugs called GLP-1 agonists – these can also be called GLP-1 analogues, GLP-1 RAs and incretin mimetics. It contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines. It is not known if Wegovy® is safe and effective for use in children under 12 years of age.
Wegovy Semaglutide is available as pre-filled pens containing a solution for injection. It is injected once a week under the skin in the belly, thigh or upper arm. To reduce the risk of symptoms affecting the gut, the weekly dose is gradually increased over 16 weeks. Patients can administer the medicine themselves. The medicine can only be obtained with a prescription. For more information about using Wegovy, see the package leaflet or contact your healthcare provider.
Wegovy Semaglutide is designed to reduce appetite, so you eat less. This means it can help you stay full for longer, which can lead to weight loss. The active substance in Wegovy, semaglutide, is a ‘GLP-1 receptor agonist’. It acts in the same way as GLP-1 (a natural hormone in the body) and, among other things, appears to regulate appetite by increasing a person’s feelings of fullness, while reducing their food intake, hunger and cravings.
The amount of weight you might lose on Wegovy will depend on your personal circumstances, as well as the support you receive from your healthcare team and how long you take this medication for. Wegovy Semaglutide is an injection that you take once a week. Your healthcare team will give you more information about how to take it.
